Access to anti-retroviral drugs, female in United Arab Emirates

United Arab Emirates: Access to anti-retroviral drugs, female was 97.0% in 2024. ◆ Volatile

Latest (2024)
97.0%
Change on year
up 9.0%
World rank
12th
of 141 countries
All-time high
97.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in United Arab Emirates, 2000–2024

0204060801002000201220242000: 0 %2001: 19 %2002: 22 %2003: 22 %2004: 23 %2005: 25 %2006: 25 %2007: 24 %2008: 24 %2009: 26 %2010: 28 %2011: 31 %2012: 40 %2013: 41 %2014: 31 %2015: 30 %2016: 18 %2017: 27 %2018: 37 %2019: 32 %2020: 59 %2021: 96 %2022: 86 %2023: 89 %2024: 97 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, female in United Arab Emirates stood at 97.0%. That is the highest value across all 25 years on record.

The figure is up 9.0% on the previous year and up 212.9% over ten years.

Over the whole period, access to anti-retroviral drugs, female in United Arab Emirates peaked at 97.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places United Arab Emirates 12th out of 141 countries with data for 2024, putting it in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in United Arab Emirates, year by year

Annual values for Access to anti-retroviral drugs, female (%) in United Arab Emirates, 2000 to 2024.
Year % Change
2000 0.0%
2001 19.0%
2002 22.0% +15.8%
2003 22.0% +0.0%
2004 23.0% +4.5%
2005 25.0% +8.7%
2006 25.0% +0.0%
2007 24.0% -4.0%
2008 24.0% +0.0%
2009 26.0% +8.3%
2010 28.0% +7.7%
2011 31.0% +10.7%
2012 40.0% +29.0%
2013 41.0% +2.5%
2014 31.0% -24.4%
2015 30.0% -3.2%
2016 18.0% -40.0%
2017 27.0% +50.0%
2018 37.0% +37.0%
2019 32.0% -13.5%
2020 59.0% +84.4%
2021 96.0% +62.7%
2022 86.0% -10.4%
2023 89.0% +3.5%
2024 97.0% +9.0%

United Arab Emirates compared with similar countries

  • United Arab Emirates's 97.0% is above the median for high income countries, which is 82.0%, 1.2× the median. (39 countries reporting)
  • United Arab Emirates's 97.0% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 55.0%, 1.8× the median. (20 countries reporting)

Biggest year-on-year movements

Years where Access to anti-retroviral drugs, female in United Arab Emirates changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2020 +84.4% 32.0% 59.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 21.0% 0.0% 26.0% 10
2010s 31.5% 18.0% 41.0% 10
2020s 85.4% 59.0% 97.0% 5

Countries ranked near United Arab Emirates

  1. 12 Rwanda 97.0% compare
  2. 14 Liberia 96.0% compare
  3. 14 Sweden 96.0% compare
  4. 14 Togo 96.0% compare
  5. 14 United Kingdom of Great Britain and Northern Ireland 96.0% compare
  6. 14 Zambia 96.0% compare

See the full ranking of 160 places →

More gender data for United Arab Emirates

All data for United Arab Emirates →

Frequently asked questions

What is access to anti-retroviral drugs, female in United Arab Emirates?
Access to anti-retroviral drugs, female in United Arab Emirates was 97.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in United Arab Emirates?
The highest recorded value was 97.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in United Arab Emirates?
The lowest recorded value was 0.0% in 2000.
How does United Arab Emirates rank for access to anti-retroviral drugs, female?
United Arab Emirates ranks 12th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in United Arab Emirates?
Over the last ten years it is up 212.9%. The long-run trend across the full record is volatile.
Where does this United Arab Emirates data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in United Arab Emirates. Statizoid, drawing on UNAIDS estimates. Retrieved 14 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/united-arab-emirates/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/united-arab-emirates/">Access to anti-retroviral drugs, female in United Arab Emirates</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.